Korea’s groundbreaking ginseng company, Il Hwa Co Ltd, just announced the formation of a wholly-owned U.S. subsidiary, Ilhwa North America Inc, which is launching a high absorption ginseng extract utilizing a patented high yield enzyme fermented process. This unique ginseng extract promises to be a game changer in the ingredient market by delivering higher efficacy, consistent absorption, improved taste profile, plus a lower cost per use.
“Today, we are proud to announce yet another important breakthrough in ginseng technology,” said David C. Konn, president of Il Hwa North America. “Our researchers have found a way to resolve the three most important concerns of manufacturers and formulators with ginseng: increased efficacy, better taste, and lower cost.”
Il Hwa Co Ltd, is a high tech pharmaceutical and nutraceutical company with 3 divisions: Ginseng, Pharmaceuticals and Beverages. Through continuous scientific research and development for more than four decades, Ilhwa has become the world leader in ginseng science.
They are fully KFDA compliant and GMP and ISO certified, holding numerous patents and the publications of 100’s of papers and clinical studies. In 2011, Ilhwa received KFDA approval for a “certified health claim” on it new enzyme fermented ginseng extract to claim “helps to manage blood glucose”. Ilhwa is the first ginseng company to receive this certification.
Konn continued, “It is the ideal time for Ilhwa to begin Ilhwa North America Inc, as we introduce our patented high absorption ginseng extract, called “GinST 15”. With offices in NY, FL and NV, our US corporation will enable us to provide world class direct service and collaboration for our customers in North America. Our company is driven by a single passion…to bring wellness to humanity across the globe through this incredible herb.”
“We call GinST 15, “the 21st Century Ginseng Extract”. We are confident that it will be a game changer in the ingredient market. Ginseng has long been a valuable ingredient for the functional food and nutraceuticals markets. However manufacturers and formulators have had problems with ginseng taste, consistent efficacy, and cost. GinST 15 solves all three problems. Also, since it is coming from the world leader in ginseng science and it is clinically proven and patented; manufacturers and formulators can trust it.”
GinST 15 utilizes several advances developed by the Il Hwa research team. “Our patented technology increases the delivery of the ginseng to be fifteen times more absorbable in the bloodstream—and it speeds the rate of absorption to be four times faster and 3 times more consistent absorption,” Konn said.
“Over the past decade, Il Hwa’s scientists developed several new enzyme processes to increase the bio-availability of ginseng in the body. GinST 15 is the result.” This product allows formulators to have a high-quality ginseng ingredient that is cost-effective, and equally as important, it helps to solve ginseng taste profile challenge.
“This is the trifecta—quality, cost and taste,” said Konn. “We at Il Hwa North America believe this gives the industry leaders in nutraceuticals and health products a wonderful opportunity to utilize the highest grade of this health-enhancing herb in their products. Also, Ginseng has so many applications.”
Il Hwa North America will host a special introductory exhibit at Nutracon in Anaheim, California on March 7th and 8th. That exhibit will be followed by one at Engredea, Booth #235 on March 9th to 11th, as well as at the Supply Market Place on May 7th and 8th in New York City.
Media and nutrition professionals are welcome to attend, and learn how one of the world’s oldest herbs is now even more usable in their products and formulations, thanks to the breakthroughs of the GinST 15 developers.